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The ACTOne cannabinoid receptor 1 functional system is com-
prised of transfected HEK cells with the parental cyclic nucleotide
gated channel (CNG) co-transfected with cannabinoid receptor 1
(CB1). The ACTOne CB1 cell line was evaluated for cAMP driven
ﬂuorescence by optimizing experimental conditions for sensitivity
to forskolin and CP 55,940, reading time point, reliability of cell
passage number, and pertussis inactivation of Gi/o.
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 These data establish a new functional cell line that evaluates putative CB1 ligands for pharmaco-
logic activity.
 The ﬂuorescent detection of cAMP changes allows for a high throughput method of detection that
can then be compared to the parental cell line to determine off-target inﬂuences.
 This system can also be pretreated with pertussis toxin to reveal CB1 Gs coupling speciﬁc to
cannabinoid ligands.1. Data
The ACTOne CB1 cell line was optimized for experimental conditions related to 96 well plate
reader detection of cAMP driven ﬂuorescence. Cells were probed for optimal forskolin stimulation of
cAMP driven ﬂuorescence, the concentration of CB1 agonist CP 55,940 needed to suppress cAMP
driven ﬂuorescence, as well as the time point for most stable ﬂuorescent signal. Furthermore, the
robustness of the ACTOne CB1 cells was evaluated with respect to cell passage number and the ability
of the cell line to reveal Gs coupled responses following pertussis toxin Gi/o inactivation.2. Experimental design, materials and methods
2.1. Plating conditions
Cells were plated in DMEM with 10% FBS and 1% P/S at 50,000 cells/100 mL well in 96 well poly-D-
lysine plates and left overnight at 37 °C, 5% CO2. Prior to testing, 100 mL of Membrane Potential dyeCTOne CB1 cells (black circles) and the suppression by CP 55,940 (white squares), N¼6, error is
forskolin.
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perature. Plates were read (Ex 540 nm, Em 590 nm) at baseline, and then after addition of compounds
plates were read for 60 min.
2.2. Forskolin and CP 55,490 optimization
ACTOne HEK-CNGþCB1 cells were evaluated for optimal sensitivity to forskolin driven cAMP
ﬂuorescent signal by exposing the cells to increasing concentrations of forskolin from 104 to 109 M
(Fig. 1). Fluorescent signal plateau began at 800 nM forskolin, and suppression of forskolin signal
using CB1 agonist CP 55,940 at 1 mM resulted in a signiﬁcant dextral shift in the EC50 (212.8 vs.
1284 nM, po0.0001) (Fig. 1).
Evaluation of the optimal time point for ﬂuorescent signal was determined to not be signiﬁcantly
different from 30 to 60 min, but a time point of 50 min was appropriate for technical efﬁciency andFig. 2. Kinetic evaluation of cAMP driven ﬂuorescent signal at 1 min intervals in ACTOne CB1 cells with no forskolin (baseline –
white circles) and 800 nM forskolin (white squares). N¼20, error is SEM.
Fig. 3. Normalized signal cAMP driven ﬂuorescence of CP 55,490 in ACTOne CB1 cells from passage 3 to 36. N¼26 from all
control runs in [2] with EC50 7.0071.2 nM, error bars are SEM.
Fig. 4. Pertussis inactivation of Gi/o in ACTOne CB1 cells reveals Gs coupling. N¼6, error is SEM.
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incubation.
Response of ACTOne CB1 cells was normalized to forskolin as maximum signal and a blank
baseline as minimum signal. The normalized response of ACTOne CB1 cells was determined to be
robust and reproducible with respect to CP 55,490 suppression of cAMP from passages 3–36 (Fig. 3).
2.3. Pertussis toxin optimization
The optimal pertussis toxin (PTx) dose of 4 ng/mL was determined to reveal CB1 Gs coupling
associated with CP 55,940 (Fig. 4). While increasing concentrations of PTx did not result in statistically
signiﬁcant changes in cAMP driven ﬂuorescence, signal was lower at 400 ng/mL and visual inspection
revealed lower cell conﬂuence at higher PTx concentrations (Fig. 5).
2.4. Kinetic evaluation
Experiments with ACTOne CB1 cells were run for 60 min and cAMP signals were evaluated at one
minute intervals. Codex Biosolutions recommended reading ﬂuorescence at 50 min [1]. Fluorescent
signal was not signiﬁcantly different from 60 min (p¼0.792, t-test).
2.5. Normalization
ACTOne assay data were normalized using a feature scaling equation:
X0 ¼ A XXminð Þ BAð Þ
XmaxXmin
where forskolin only stimulation is the experimental maximum B, a blank well with dye and cells
only is the experimental minimum A, normalized value is Xʹ, Xmax is 100%, and Xmin is 0%. Data were
then analyzed using non-linear regression analysis.
2.6. Pertussis Inactivation studies
Pertussis (PTx) dose response was performed in ACTOne CB1 cells with 0, 4, 40, or 400 ng/mL
(Fig. 4). Cells were incubated overnight with PTx and run against CP 55,940 the next day. Visual
inspected indicated that higher concentrations of PTx resulted in lower cell attachment to plates
(Fig. 5). 4 ng/mL of PTx resulted in the strongest CP 55,940 Gs effect on cAMP while giving the best
cellular conﬂuence.
Fig. 5. Overnight treatment of ACTOne CB1 cells with PTx: (A) 0 ng/mL, (B) 4 ng/mL, (C) 40 ng/mL, and (D) 400 ng/mL revealed
lower cell conﬂuence with higher concentrations.
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